Literature DB >> 8904939

Common biological pathways in eating disorders and obesity.

M Ericsson1, W S Poston, J P Foreyt.   

Abstract

The purpose of this article is to summarize briefly potential biological pathways that are common among anorexia nervosa, bulimia nervosa, and obesity. We conclude that data on serotonergic and beta-endorphin regulatory systems provide the most promising leads for potential trait-based etiological theories. We then discuss the contribution of current data to a better understanding of the etiology and maintenance of eating disorders. Finally, we comment on how the exploration for common biological mechanisms highlights problems in nosological diagnosis (i.e., the lack of symptom specificity among disorders) and obscures the etiological significance of social stressors and cultural factors.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8904939     DOI: 10.1016/0306-4603(96)00032-9

Source DB:  PubMed          Journal:  Addict Behav        ISSN: 0306-4603            Impact factor:   3.913


  4 in total

1.  D4 dopamine receptor gene exon III polymorphism and obesity risk.

Authors:  W S Poston; M Ericsson; J Linder; C K Haddock; C L Hanis; T Nilsson; M Aström; J P Foreyt
Journal:  Eat Weight Disord       Date:  1998-06       Impact factor: 4.652

2.  Effects of restraint stress and serotonin on macronutrient selection: a rat model of stress-induced anorexia.

Authors:  S W J Wang
Journal:  Eat Weight Disord       Date:  2002-03       Impact factor: 4.652

3.  Can body mass index help predict outcome in patients with bipolar disorder?

Authors:  Cynthia Calkin; Caroline van de Velde; Martina Růzicková; Claire Slaney; Julie Garnham; Tomas Hajek; Claire O'Donovan; Martin Alda
Journal:  Bipolar Disord       Date:  2009-09       Impact factor: 6.744

4.  Genetic disruption of both tryptophan hydroxylase genes dramatically reduces serotonin and affects behavior in models sensitive to antidepressants.

Authors:  Katerina V Savelieva; Shulei Zhao; Vladimir M Pogorelov; Indrani Rajan; Qi Yang; Emily Cullinan; Thomas H Lanthorn
Journal:  PLoS One       Date:  2008-10-15       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.